Amit Shankar Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amit Shankar Singh has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Liza Das
Endocrinology, Post Graduate Institute of Medical Education and Research , Chandigarh, India
9 shared publicationsVirendra Atam
Department of Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India
7 shared publicationsJeenendra Prakash Singhvi
Department of Neurology, Fortis Hospital Mohali
3 shared publicationsBesthenahalli Erappa Yathish
Department of Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India
2 shared publicationsKamal Kumar Sawlani
Department of Medicine, King George’s Medical University, Uttar Pradesh, Lucknow, India
2 shared publicationsMunna Lal Patel
Department of Medicine, King George’s Medical University, Uttar Pradesh, Lucknow, India
2 shared publications
Latest Publications
- Open Access
- 15 August 2025
- Published by Mansa STM Publishers in Indian Journal of Case Reports
- Vol. 11 (8) , 407-408
Facial epilepsia partialis continua in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes
- 15 August 2025
- Published by Mansa STM Publishers in Indian Journal of Case Reports
- Vol. 11 (8) , 407-408
Open AccessFacial epilepsia partialis continua in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes
- Open Access
- 30 September 2023
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 16 (3) , 336-338
Pisa Syndrome in Subacute Sclerosing Panencephalitis: A Case Report and Review of the Literature
- 30 September 2023
- Published by The Korean Movement Disorder Society in Journal of Movement Disorders
- Vol. 16 (3) , 336-338
Open AccessPisa Syndrome in Subacute Sclerosing Panencephalitis: A Case Report and Review of the Literature
- Open Access
- 18 January 2023
- Published by Scientific Scholar in Journal of Neurosciences in Rural Practice
- Vol. 14 (3) , 551-553
Para-choreo-ballism due to pinealoma in an elderly lady
- 18 January 2023
- Published by Scientific Scholar in Journal of Neurosciences in Rural Practice
- Vol. 14 (3) , 551-553
Open AccessPara-choreo-ballism due to pinealoma in an elderly lady
- Open Access
- 20 June 2022
- Published by Scientific Scholar in Journal of Neurosciences in Rural Practice
- Vol. 13 (03) , 561-562
Orthostatic Myoclonic Jerks in a Case of Hashimoto's Encephalopathy
Hashimoto's encephalopathy (HE) is an uncommon syndrome with the characteristic triad of positive antithyroid antibodies (most commonly antibodies to thyroid peroxidase), response to steroids, and clinical picture presenting either as stroke-like pattern of focal neurological deficit or slowly progressive cognitive impairment. Myoclonus or tremors, seizures, and psychosis are other associated features which can be seen in HE. Herein, we report a girl with an uncommon presentation of orthostatic axial and myoclonic jerks in bilateral lower limbs in a case of HE.
- 20 June 2022
- Published by Scientific Scholar in Journal of Neurosciences in Rural Practice
- Vol. 13 (03) , 561-562
Open AccessOrthostatic Myoclonic Jerks in a Case of Hashimoto's Encephalopathy
Hashimoto's encephalopathy (HE) is an uncommon syndrome with the characteristic triad of positive antithyroid antibodies (most commonly antibodies to thyroid peroxidase), response to steroids, and clinical picture presenting either as stroke-like pattern of focal neurological deficit or slowly progressive cognitive impairment. Myoclonus or tremors, seizures, and psychosis are other associated features which can be seen in HE. Herein, we report a girl with an uncommon presentation of orthostatic axial and myoclonic jerks in bilateral lower limbs in a case of HE.
- 31 January 2022
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 98 (e1) , e30
Nocardiabrain abscess: a sinister aetiology
- 31 January 2022
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 98 (e1) , e30
Nocardiabrain abscess: a sinister aetiology
- 9 October 2019
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 96 (1133) , 167
Melanoleuconychia: A rare reversible entity
- 9 October 2019
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 96 (1133) , 167
Melanoleuconychia: A rare reversible entity
- Open Access
- 1 January 2019
- Published by Medknow in Annals of Indian Academy of Neurology
- Vol. 22 (1) , 116-117
Unilateral vertical pendular nystagmus in multiple sclerosis: A distinctive neuro-ophthalmological sign
Lesions in multiple sclerosis can involve brain, optic nerve and spinal cord. We here report a patient of multiple sclerosis, who had unilateral vertical pendular nystagmus, because of simultaneous involvement of optic nerve and asymmetric brain stem lesions. This specific combination is rarely seen in other disorders, therefore can be considered as a distinctive neuro-opthalmoloical sign of multiple sclerosis.
- 1 January 2019
- Published by Medknow in Annals of Indian Academy of Neurology
- Vol. 22 (1) , 116-117
Open AccessUnilateral vertical pendular nystagmus in multiple sclerosis: A distinctive neuro-ophthalmological sign
Lesions in multiple sclerosis can involve brain, optic nerve and spinal cord. We here report a patient of multiple sclerosis, who had unilateral vertical pendular nystagmus, because of simultaneous involvement of optic nerve and asymmetric brain stem lesions. This specific combination is rarely seen in other disorders, therefore can be considered as a distinctive neuro-opthalmoloical sign of multiple sclerosis.
- 1 June 2018
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 8 (3) , e9-e11
Jack-o’-lantern sign in dengue encephalitis
- 1 June 2018
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 8 (3) , e9-e11
Jack-o’-lantern sign in dengue encephalitis
- 28 February 2018
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 58 (5) , 755-757
Mirror Induced Headaches: A New Self Image Trigger for Migraine Attacks?
- 28 February 2018
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 58 (5) , 755-757
Mirror Induced Headaches: A New Self Image Trigger for Migraine Attacks?
- Open Access
- 1 December 2015
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 16 (1) , 67
Role of oral Minocycline in acute encephalitis syndrome in India – a randomized controlled trial
Acute encephalitis syndrome (AES) is a public health problem in India. Neuroinfections are believed to be the most important etiology. Minocycline is a semisythetic tetracycline having excellent penetration into cerebrospinal fluid, established neuroprotective and antiviral properties besides action on nonviral causes of AES. It has been shown to be effective in animal model of Japanese encephalitis (JE). A randomized, controlled trial of nasogastric/oral minocycline in JE and AES at a single centre in Uttar Pradesh, northern India, was therefore conducted. Patients beyond 3 years of age - but excluding women aged 16–44 years - hospitalized with AES of < =7 days duration were enrolled and block randomized to receive nasogastric/oral minocycline or placebo suspension and followed up. Patients, study personnel and those entering data were blinded as to drug or placebo received. Primary outcome was cumulative mortality at 3 months from hospitalization. Analysis was by intention to treat. 281 patients were enrolled, 140 received drug and 141 placebo. While there was no overall statistically significant difference in 3 month mortality between drug and placebo groups [RR = 0 · 83 (0 · 6-1 · 1)], there were encouraging trends in patients older than 12 years [RR = 0.70 (0.41-1.18)] and in Glasgow Outcome Score (GOS) at 3 months (χ2 = 7 · 44, p = 0 · 059). These trends were further accentuated if patients dying within one day of reaching hospital were excluded [OR for 3 month mortality =0 · 70 (0 · 46-1 · 07), p = 0.090; 3 month GOS p = 0 · 028]. A trend towards better outcomes was observed with minocycline, especially in those patients who survived the initial day in hospital. These findings should form the basis for planning a larger study and possibly including minocycline in the initial management of AES as seen here. The trial was registered with Clinical Trials Registry of India (CTRI) - CTRI/2010/091/006143
- 1 December 2015
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 16 (1) , 67
Open AccessRole of oral Minocycline in acute encephalitis syndrome in India – a randomized controlled trial
Acute encephalitis syndrome (AES) is a public health problem in India. Neuroinfections are believed to be the most important etiology. Minocycline is a semisythetic tetracycline having excellent penetration into cerebrospinal fluid, established neuroprotective and antiviral properties besides action on nonviral causes of AES. It has been shown to be effective in animal model of Japanese encephalitis (JE). A randomized, controlled trial of nasogastric/oral minocycline in JE and AES at a single centre in Uttar Pradesh, northern India, was therefore conducted. Patients beyond 3 years of age - but excluding women aged 16–44 years - hospitalized with AES of < =7 days duration were enrolled and block randomized to receive nasogastric/oral minocycline or placebo suspension and followed up. Patients, study personnel and those entering data were blinded as to drug or placebo received. Primary outcome was cumulative mortality at 3 months from hospitalization. Analysis was by intention to treat. 281 patients were enrolled, 140 received drug and 141 placebo. While there was no overall statistically significant difference in 3 month mortality between drug and placebo groups [RR = 0 · 83 (0 · 6-1 · 1)], there were encouraging trends in patients older than 12 years [RR = 0.70 (0.41-1.18)] and in Glasgow Outcome Score (GOS) at 3 months (χ2 = 7 · 44, p = 0 · 059). These trends were further accentuated if patients dying within one day of reaching hospital were excluded [OR for 3 month mortality =0 · 70 (0 · 46-1 · 07), p = 0.090; 3 month GOS p = 0 · 028]. A trend towards better outcomes was observed with minocycline, especially in those patients who survived the initial day in hospital. These findings should form the basis for planning a larger study and possibly including minocycline in the initial management of AES as seen here. The trial was registered with Clinical Trials Registry of India (CTRI) - CTRI/2010/091/006143